Loading stock data…
$25.61-0.91 (-3.43%)
Warby Parker Inc.
Warby Parker Inc. in the Healthcare sector is trading at $25.61 with a market capitalization of $2.9B. Wall Street consensus targets $30.46 (13 analysts), implying a +18.9% move over the next 12 months. The stock is currently 17% below its 52-week high of $31.00, remaining 1.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $235.51M↓ | $242.45M↑ | $211.97M↓ | $221.68M↑ | $214.47M |
| Gross Profit | $136.46M↑ | $131.04M↑ | $111.04M↓ | $119.94M↑ | $113.61M |
| Operating Income | $3.17M↑ | $1.67M↑ | -$6.85M↓ | $3.57M↑ | -$4.53M |
| Net Income | $4.64M↑ | $3.18M↑ | -$5.95M↓ | $5.87M↑ | -$1.75M |
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tint...